Evidence against the proposition that "UK cancer survival statistics are misleading": Simulation study with National Cancer Registry data

BMJ

Volumn 342, Issue 7811, 2011, Pages

  Woods, Laura M ^a   Coleman, Michel P ^a   Lawrence, Gill ^b   Rashbass, Jem ^c   Berrino, Franco ^d   Rachet, Bernard ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c Eastern Cancer Registry and Information Centre   (United Kingdom)

^d NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER REGISTRY; CANCER SURVIVAL; CAUSE OF DEATH; COLORECTAL CANCER; DEATH CERTIFICATE; FEMALE; HUMAN; LUNG CANCER; MALE; PRIORITY JOURNAL; SWEDEN; UNITED KINGDOM; NEOPLASM; RECURRENT DISEASE; REGISTER; SURVIVOR;

DEATH CERTIFICATES; FEMALE; GREAT BRITAIN; HUMANS; MALE; NEOPLASMS; RECURRENCE; REGISTRIES; SURVIVORS;

EID: 79959305893     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.d3399     Document Type: Article

References (35)

1. Berrino F, Sant M, Verdecchia A, Capocaccia R, Hakulinen T, Estève J. Survival of cancer patients in Europe: the EUROCARE study. International Agency for Research on Cancer, 1995.
2. Berrino F, Capocaccia R, Estève J, Gatta G, Hakulinen T, Micheli M, et al. Survival of cancer patients in Europe: the EUROCARE-2 study. International Agency for Research on Cancer, 1999.
3. Coleman MP, Gatta G, Verdecchia A, Estève J, Sant M, Storm H, et al. EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. Ann Oncol 2003;14:128-49v.
4. Berrino F, De Angelis R, Sant M, Rosso S, Bielska-Lasota M, Coebergh JW, et al. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study. Lancet Oncol 2007;8:773-83.
5. Coleman MP, Forman D, Bryant H, Butler J, Rachet B, Maringe C, et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet 2011;377:127-38.
6. Wilkinson E. Questions remain over validity of EUROCARE data. Lancet 2009;374:964-5.
7. Department of Health. The NHS cancer plan. Department of Health, 2000.
8. Department of Health. Cancer reform strategy. Department of Health, 2007.
9. Beral V, Peto R. UK cancer survival statistics are misleading and make survival look worse than it is. BMJ 2010;341:c4112.
10. Autier P, Boniol M, LaVecchia C, Vatten L, Gavin A, Hery C, et al. Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database. BMJ 2010;341:c3620.
11. Coleman MP, Quaresma M, Berrino F, Lutz JM, De Angelis R, Capocaccia R, et al. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol 2008;9:730-56.
12. Office for National Statistics. Cancer statistics registrations: registrations of cancer diagnosed in 2006, England. (Series MB1, no 37.) Office for National Statistics, 2008.
13. Ederer F, Axtell LM, Cutler SJ. The relative survival: a statistical methodology. Natl Cancer Inst Monogr 1961;6:101-21.
14. Brenner H, Gefeller O. Deriving more up-to-date estimates of long-term patient survival. J Clin Epidemiol 1997;50:211-6. (Pubitemid 27129721)
15. Estève J, Benhamou E, Croasdale M, Raymond L. Relative survival and the estimation of net survival: elements for further discussion. Stat Med 1990;9:529-38. (Pubitemid 20235022)
16. Cancer Research UK Cancer Survival Group. Strel [computer program version 5.8] and life tables for cancer survival analysis. London School of Hygiene and Tropical Medicine, 2006.
17. EUROCARE-4 database. EUROCARE: survival of cancer patients in Europe. 2011. www.eurocare.it.
18. Rachet B, Maringe C, Nur U, Quaresma M, Shah A, Woods LM, et al. Population-based cancer survival trends in England and Wales up to 2007: an assessment of the NHS cancer plan for England. Lancet Oncol 2009;10:351-69.
19. Woods LM, Rachet B, O'Connell D, Lawrence G, Tracey E, Willmore A, et al. Large differences in patterns of breast cancer survival between Australia and England: a comparative study using cancer registry data. Int J Cancer 2009;124:2391-9.
20. Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, et al. Cancer incidence in five continents, volume IX. International Agency for Research on Cancer, 2007.
21. Kaye JA, Derby LE, Mar Melero-Montes M, Quinn M, Jick H. The incidence of breast cancer in the general practice research database compared with national cancer registration data. Br J Cancer 2000;83:1556-8.
22. Stotter A, Bright N, Silcocks PB, Botha JL. Effect of improved data collection on breast cancer incidence and survival: reconciliation of a registry with a clinical database. BMJ 2000;321:214. (Pubitemid 30459559)
23. Berrino F. The EUROCARE study: strengths, limitations and perspectives of population-based, comparative survival studies. Ann Oncol 2003;14(suppl 5):v9-13.
24. Brenner H, Hakulinen T. Implications of incomplete registration of deaths on long-term survival estimates from population-based cancer registries. Int J Cancer 2009;125:432-7.
25. Maudsley G, Williams EM. "Inaccuracy" in death certification-where are we now? J Public Health Med 1996;18:59-66.
26. Devis T, Rooney C. Death certification and the epidemiologist. Health Stat Quart 1999;1:21-33.
27. Laurenti R, Coleman MP, Aylin P. Accuracy of statements of the cause of death on death certificates and the international comparability of mortality statistics. In: Coleman MP, Aylin P, eds. Death certification and mortality statistics: an international perspective. Office for National Statistics, 2000.
28. Bray F, Parkin DM. Evaluation of data quality in the cancer registry: principles and methods. Part I: comparability, validity, and timeliness. Eur J Cancer 2009;45:747-55.
29. UK Association of Cancer Registries. UKACR quality and performance indicators 2009: final. UKACR, 2010.
30. Sant M, Allemani C, Capocaccia R, Hakulinen T, Aareleid T, Coebergh JW, et al. Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe. Int J Cancer 2003;106:416-22. (Pubitemid 36870406)
31. Anderson GF, Frogner BK, Reinhardt UE. Health spending in OECD countries in 2004: an update. Health Aff (Millwood) 2007;26:1481-9.
32. Organisation for Economic Co-operation and Development. Health at a glance 2009. 2009. www.oecd.org/document/14/0,3343,en-2649-34631-16502667-1-1-1- 1,00.html.
33. Bentzen SM, Heeren G, Cottier B, Slotman B, Glimelius B, Lievens Y, et al. Towards evidence-based guidelines for radiotherapy infrastructure and staffing needs in Europe: the ESTRO QUARTS project. Radiother Oncol 2005;75:355-65. (Pubitemid 41007983)
34. Williams MV, Summers ET, Drinkwater K, Barrett A. Radiotherapy dose fractionation, access and waiting times in the countries of the UK in 2005. Clin Oncol (R Coll Radiol) 2007;19:273-86.
35. Williams MV, Drinkwater KJ. Radiotherapy in England in 2007: modelled demand and audited activity. Clin Oncol (R Coll Radiol) 2009;21:575-90.